Urogen Pharma Ltd (URGN)

EBITDA Margin

-37.16%

TTM · Period ending:

URGN logo

URGN EBITDA Margin

Latest reported-37.16%
URGN TTM EBITDA Margin (5.77% → -37.16%)
High-resolution chart · PNG

URGN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Urogen Pharma Ltd EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-37.156%
-82.4077%
-123.5654%
-144.7677%
-136.5012%
-119.1442%
-104.3685%
-84.507%
-85.8912%
-75.0469%
-79.4265%
-107.1239%
-127.6806%
-133.5809%
-142.8594%
-139.139%
-164.0459%
-188.4666%
-208.8943%
-270.0005%
-333.1424%
-582.2236%
-1,049.9534%
-3,546.778%
-35,137.0968%
-683,766.6667%
-600,855.5556%
-518,838.8889%
-30,243.8538%
-13,249.459%
-6,804.4326%
-4,323.9863%
-469.3789%
-343.9675%
-242.0078%
17.1089%
-8.1372%
6.1485%
5.7673%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.